David Roman

Stock Analyst at Goldman Sachs

(0.89)
# 2257
Out of 5,370 analysts
43
Total ratings
40.00%
Success rate
5.87%
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
HQY HealthEquity
Maintains: Neutral
94 104
101.03 2.94% 3 Jun 4, 2025
BBNX Beta Bionics
Initiates Coverage On: Neutral
16
19.53 -18.07% 1 May 30, 2025
PODD Insulet
Initiates Coverage On: Buy
380
305.89 24.23% 1 May 30, 2025
DOCS Doximity
Maintains: Neutral
80 50
56.02 -10.75% 3 May 21, 2025
ZBH Zimmer Biomet Holdin...
Maintains: Neutral
120 104
92.12 12.9% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 10
7.03 42.25% 4 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
94 82
72.78 12.67% 3 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
24 23
16.68 37.89% 2 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
138 154
133.99 14.93% 2 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
42 24
20 20% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
63 71
74.46 -4.65% 4 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
64 55
45.45 21.01% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
42
30.74 36.63% 3 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
91 124
144.35 -14.1% 2 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
384 427
376.8 13.32% 2 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
81 90
74.71 20.47% 3 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
90
101.47 -11.3% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
500
518.65 -3.6% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
274
172.18 59.14% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
83
87.94 -5.62% 1 May 30, 2024